SPYRAL DYSTAL Renal Denervation Global Clinical Study

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

June 12, 2020

Primary Completion Date

December 22, 2022

Study Completion Date

December 22, 2022

Conditions
HypertensionVascular DiseasesCardiovascular Diseases
Interventions
DEVICE

Renal Denervation (Symplicity Spyral™)

Device: Symplicity Spyral™ multi-electrode renal denervation system. After a renal angiography according to standard procedures, subjects are treated with the renal denervation procedure.

Trial Locations (8)

30309

Piedmont Heart Institute, Atlanta

75226

Baylor Heart & Vascular Hospital, Dallas

94305

Stanford Hospital and Clinics, Stanford

Unknown

Universitaetsklinikum Erlangen, Erlangen

Universitaetsklinikum des Saarlandes, Homburg

Herzzentrum Leipzig, Leipzig

Hippokration General Hospital of Athens, Athens

University Hospital of Wales, Cardiff

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY